TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
DXR

Daxor Corporation

Healthcare · Medical Instruments & Supplies

11.40$ +3.1% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow DXR
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – -91.4% -173.6% – – -178.7% – – – – -2,452.6%
– +237.6% +37.0% +30.8% +520.6% +137.8% +89.4% +93.1% +7.9% -19.7% +97.2% –
– +708.6% -99.0% -639.4% – – -120.7% – – – – –
– – -149.6% – -122.0% – -118.5% – -104.2% – -73.2% +50.6%
– – – – – – – – +33.3% -75.0% +300.0% -100.0%
– – – – – – -92.9% -79.7% +3,498.6% +2.1% -29.3% -39.4%
– +28.7% -26.0% -1.7% – – – – – – – –
– +23.6% -49.4% -43.0% -87.0% – – – – – – –
– -1,675.8% -94.0% – -92.2% -2,692.0% -62.3% – -162.9% -73.6% -94.6% +2,742.2%
– -6,366.4% -91.4% – -80.7% -1,474.6% – -7.0% -97.9% +6,137.5% -100.7% +2,122.2%
– +728.2% -165.1% – – – -88.1% -85.0% -865.0% – – –
– – -91.4% -173.6% – – -178.7% – – – – -2,452.6%

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?